ES/IODE's Avatar

ES/IODE

@esiode.bsky.social

Online scientific research platform ๐Ÿ”ฌ๐Ÿ”ญ๐Ÿฅผ๐Ÿงช | Access reliable articles and streamline your scientific writing. | Curating the latest scientific news. | Knowledge broker: a selection of scientific papers on Bluesky. Try it on ethicseido.com/Iode

246 Followers  |  2 Following  |  27,611 Posts  |  Joined: 14.02.2024  |  1.4027

Latest posts by esiode.bsky.social on Bluesky

๐Ÿ“ƒScientific paper: The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 16:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Transcriptome Analysis Reveals Differentially Expressed circRNAs Associated with Fecundity in Small-Tail Han Sheep Thyroid with Different FecB Genotypes

Ref.: MDPI, 2023

โžก๏ธ Continued on ES/IODE

31.10.2025 15:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Utility of a Short-Form Phonemic Fluency Task

Ref.: Oxford University Press, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 14:40 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Prodromal Parkinson disease signs are predicted by a whole-blood inflammatory transcriptional signature in young Pink1(โˆ’/โˆ’) rats

Ref.: BioMed Central, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 14:39 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Spatial Altimetry, GNSS Reflectometry and Marine Surcotes;Altimรฉtrie Spatiale, Rรฉflectomรฉtrie GNSS et Surcotes Marines

Ref.: HAL CCSD, 2019

โžก๏ธ Continued on ES/IODE

31.10.2025 14:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Spectroscopic Mapping of Callisto with HST/STIS and Implications for its
Surface Composition

Ref.: arXiv, 2025

โžก๏ธ Continued on ES/IODE

31.10.2025 13:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinsonโ€™s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

Ref.: HAL CCSD;Springer Verlag, 2023

โžก๏ธ Continued on ES/IODE

31.10.2025 12:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: The relationship between thyroid autoantibodies and X chromosome monosomy in the chorionic tissue of patients with missed miscarriage

Ref.: BioMed Central, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 11:42 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Migration-related determinants of health-care service utilization among persons with a direct migration background in Germany: an exploratory study based on the German Socio-Economic Panel (SOEP)

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 11:41 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: LncRNA PCED1B-AS1 mediates miR-3681-3p/MAP2K7 axis to promote metastasis, invasion and EMT in gastric cancer

Ref.: BioMed Central, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 11:39 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects

Ref.: BioMed Central, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 11:37 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Comparative analysis of proteomic adaptations in Enterococcus faecalis and Enterococcus faecium after long term bile acid exposure

Ref.: BioMed Central, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 11:33 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Fungi

Ref.: Springer, 2025

โžก๏ธ Continued on ES/IODE

31.10.2025 11:24 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Mixed methods system for the assessment of post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an exploratory study

Ref.: BMJ Publishing Group, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 11:00 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Towards unlocking the biocontrol potential of Pichia kudriavzevii for plant fungal diseases: in vitro and in vivo assessments with candidate secreted protein prediction

Ref.: BioMed Central, 2023

โžก๏ธ Continued on ES/IODE

31.10.2025 10:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Unmasking Individual and Institutional HIV Stigma in Hospitals: Perspectives of Dutch Healthcare Providers

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 08:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Long COVID risk by pre-infection symptoms and functional status: A retrospective cohort study of data from the All of Us Research Program.

Ref.: Cold Spring Harbor Laboratory, 2025

โžก๏ธ Continued on ES/IODE

31.10.2025 07:00 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Incidents During Microservice Decomposition: A Case Study

Ref.: arXiv, 2025

โžก๏ธ Continued on ES/IODE

31.10.2025 06:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 05:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: AXIAL: Attention-based eXplainability for Interpretable Alzheimer's
Localized Diagnosis using 2D CNNs on 3D MRI brain scans

Ref.: arXiv, 2024

โžก๏ธ Continued on ES/IODE

31.10.2025 04:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Cannabis and pathologies in dogs and cats: first survey of phytocannabinoid use in veterinary medicine in Argentina

Ref.: BioMed Central, 2023

โžก๏ธ Continued on ES/IODE

30.10.2025 19:03 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Bulbar-onset amyotrophic lateral sclerosis in a patient with genetically confirmed Huntingtonโ€™s disease: a case study

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

30.10.2025 18:02 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Smoking, Urban Housing and Work-Aggravated Asthma are Associated with Asthma Severity in a Cross-Sectional Observational Study

Ref.: Dove, 2024

โžก๏ธ Continued on ES/IODE

30.10.2025 17:02 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Comparative analysis of genetic risk scores for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy

Ref.: BioMed Central, 2024

โžก๏ธ Continued on ES/IODE

30.10.2025 16:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis

Ref.: Springer, 2024

โžก๏ธ Continued on ES/IODE

30.10.2025 15:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: The Relationship Between Participation in Maternal Health Care Decision-Making and the Selection of Birth Assistants

Ref.: Springer, 2023

โžก๏ธ Continued on ES/IODE

30.10.2025 14:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Correcting for the effects of the point spread function in intra-halo
light measurements and application to deep Hyper Suprime-Cam data

Ref.: arXiv, 2025

โžก๏ธ Continued on ES/IODE

30.10.2025 13:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: Investigating Brain Connectivity and Regional Statistics from EEG for
early stage Parkinson's Classification

Ref.: arXiv, 2024

โžก๏ธ Continued on ES/IODE

30.10.2025 12:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ“ƒScientific paper: DNA methylation differences in genes associated with human personal disorders and deviant behavior

Ref.: AIMS Press, 2024

โžก๏ธ Continued on ES/IODE

30.10.2025 11:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@esiode is following 2 prominent accounts